George A. Scangos

2017 - Biogen

In 2017, George A. Scangos earned a total compensation of $7.5M as Former Chief Executive Officer at Biogen, a 58% decrease compared to previous year.

Compensation breakdown

Change in Pension Value and Nonqualified Deferred Compensation Earnings$159,968
Salary$60,065
Other$7,255,796
Total$7,475,829

Scangos received $7.3M in other compensation, accounting for 97.06% of the total pay in 2017.

Scangos also received $160K of change in pension value and nonqualified deferred compensation earnings and $60.1K in salary.

Rankings

In 2017, George A. Scangos' compensation ranked 1,001st out of 14,102 executives tracked by ExecPay. In other words, Scangos earned more than 92.9% of executives.

ClassificationRankingPercentile
All
1,001
out of 14,102
93rd
Division
Manufacturing
340
out of 5,593
94th
Major group
Chemicals And Allied Products
88
out of 1,980
96th
Industry group
Drugs
59
out of 1,641
96th
Industry
Biological Products, Except Diagnostic Substances
9
out of 292
97th
Source: SEC filing on April 27, 2018.

Scangos' colleagues

We found eight more compensation records of executives who worked with George A. Scangos at Biogen in 2017.

2017

Michel Vounatsos

Biogen

Chief Executive Officer

2017

Kenneth DiPietro

Biogen

Former Executive Vice President, Human Resources

2017

Michael Ehlers

Biogen

Executive Vice President, Research & Development

2017

Susan Alexander

Biogen

Chief Legal Officer

2017

Paul McKenzie

Biogen

Executive Vice President, Pharmaceutical Operations & Technology

2017

Paul Clancy

Biogen

Chief Financial Officer

2017

Gregory Covino

Biogen

Chief Accounting Officer

2017

Jeffrey Capello

Biogen

Chief Financial Officer

You may also like